BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 28641467)

  • 1. Green tea polyphenol EGCG causes anti-cancerous epigenetic modulations in acute promyelocytic leukemia cells.
    Borutinskaitė V; Virkšaitė A; Gudelytė G; Navakauskienė R
    Leuk Lymphoma; 2018 Feb; 59(2):469-478. PubMed ID: 28641467
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Belinostat, a potent HDACi, exerts antileukaemic effect in human acute promyelocytic leukaemia cells via chromatin remodelling.
    Valiuliene G; Stirblyte I; Cicenaite D; Kaupinis A; Valius M; Navakauskiene R
    J Cell Mol Med; 2015 Jul; 19(7):1742-55. PubMed ID: 25864732
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Anti-leukemic effects of HDACi Belinostat and HMTi 3-Deazaneplanocin A on human acute promyelocytic leukemia cells.
    Valiulienė G; Stirblytė I; Jasnauskaitė M; Borutinskaitė V; Navakauskienė R
    Eur J Pharmacol; 2017 Mar; 799():143-153. PubMed ID: 28192098
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epigenetic and genetic mechanisms contribute to telomerase inhibition by EGCG.
    Berletch JB; Liu C; Love WK; Andrews LG; Katiyar SK; Tollefsbol TO
    J Cell Biochem; 2008 Feb; 103(2):509-19. PubMed ID: 17570133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Epigallocatechin-3-gallate and BIX-01294 have different impact on epigenetics and senescence modulation in acute and chronic myeloid leukemia cells.
    Vitkeviciene A; Baksiene S; Borutinskaite V; Navakauskiene R
    Eur J Pharmacol; 2018 Nov; 838():32-40. PubMed ID: 30194939
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Novel Clofarabine-Based Combinations with Polyphenols Epigenetically Reactivate Retinoic Acid Receptor Beta, Inhibit Cell Growth, and Induce Apoptosis of Breast Cancer Cells.
    Lubecka K; Kaufman-Szymczyk A; Cebula-Obrzut B; Smolewski P; Szemraj J; Fabianowska-Majewska K
    Int J Mol Sci; 2018 Dec; 19(12):. PubMed ID: 30544666
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetic induction of tissue inhibitor of matrix metalloproteinase-3 by green tea polyphenols in breast cancer cells.
    Deb G; Thakur VS; Limaye AM; Gupta S
    Mol Carcinog; 2015 Jun; 54(6):485-99. PubMed ID: 24481780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Green tea-induced epigenetic reactivation of tissue inhibitor of matrix metalloproteinase-3 suppresses prostate cancer progression through histone-modifying enzymes.
    Deb G; Shankar E; Thakur VS; Ponsky LE; Bodner DR; Fu P; Gupta S
    Mol Carcinog; 2019 Jul; 58(7):1194-1207. PubMed ID: 30854739
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Green tea polyphenol EGCG reverse cisplatin resistance of A549/DDP cell line through candidate genes demethylation.
    Zhang Y; Wang X; Han L; Zhou Y; Sun S
    Biomed Pharmacother; 2015 Feb; 69():285-90. PubMed ID: 25661371
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The Bmi-1 polycomb protein antagonizes the (-)-epigallocatechin-3-gallate-dependent suppression of skin cancer cell survival.
    Balasubramanian S; Adhikary G; Eckert RL
    Carcinogenesis; 2010 Mar; 31(3):496-503. PubMed ID: 20015867
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigallocatechin-3-gallate (EGCG) Alters Histone Acetylation and Methylation and Impacts Chromatin Architecture Profile in Human Endothelial Cells.
    Ciesielski O; Biesiekierska M; Balcerczyk A
    Molecules; 2020 May; 25(10):. PubMed ID: 32429384
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potentiation of growth inhibition and epigenetic modulation by combination of green tea polyphenol and 5-aza-2'-deoxycytidine in human breast cancer cells.
    Tyagi T; Treas JN; Mahalingaiah PK; Singh KP
    Breast Cancer Res Treat; 2015 Feb; 149(3):655-68. PubMed ID: 25663548
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Green tea polyphenols and its constituent epigallocatechin gallate inhibits proliferation of human breast cancer cells in vitro and in vivo.
    Thangapazham RL; Singh AK; Sharma A; Warren J; Gaddipati JP; Maheshwari RK
    Cancer Lett; 2007 Jan; 245(1-2):232-41. PubMed ID: 16519995
    [TBL] [Abstract][Full Text] [Related]  

  • 14. (-)-Epigallocatechin-3-gallate induces apoptosis and differentiation in leukaemia by targeting reactive oxygen species and PIN1.
    Della Via FI; Shiraishi RN; Santos I; Ferro KP; Salazar-Terreros MJ; Franchi Junior GC; Rego EM; Saad STO; Torello CO
    Sci Rep; 2021 Apr; 11(1):9103. PubMed ID: 33907248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Green tea polyphenol EGCG suppresses osteosarcoma cell growth through upregulating miR-1.
    Zhu K; Wang W
    Tumour Biol; 2016 Apr; 37(4):4373-82. PubMed ID: 26499783
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigallocatechin-3-gallate enhances differentiation of acute promyelocytic leukemia cells via inhibition of PML-RARα and HDAC1.
    Moradzadeh M; Roustazadeh A; Tabarraei A; Erfanian S; Sahebkar A
    Phytother Res; 2018 Mar; 32(3):471-479. PubMed ID: 29193405
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epigenetic and molecular mechanisms underlying the antileukemic activity of the histone deacetylase inhibitor belinostat in human acute promyelocytic leukemia cells.
    Savickiene J; Treigyte G; Valiuliene G; Stirblyte I; Navakauskiene R
    Anticancer Drugs; 2014 Sep; 25(8):938-49. PubMed ID: 24800886
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Epigallocatechin Gallate (EGCG) is the most effective cancer chemopreventive polyphenol in green tea.
    Du GJ; Zhang Z; Wen XD; Yu C; Calway T; Yuan CS; Wang CZ
    Nutrients; 2012 Nov; 4(11):1679-91. PubMed ID: 23201840
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Difference in growth suppression and apoptosis induction of EGCG and EGC on human promyelocytic leukemia HL-60 cells.
    Han DH; Kim JH
    Arch Pharm Res; 2009 Apr; 32(4):543-7. PubMed ID: 19407972
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epigallocatechin-3-gallate promotes all-trans retinoic acid-induced maturation of acute promyelocytic leukemia cells via PTEN.
    Yao S; Zhong L; Chen M; Zhao Y; Li L; Liu L; Xu T; Xiao C; Gan L; Shan Z; Liu B
    Int J Oncol; 2017 Sep; 51(3):899-906. PubMed ID: 28766684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.